FindTrial
Sign In

comparison of the new device Elisar AVA s updated algorithm and it current algorithm

Comparison of threshold estimates of current version Elisar 30-2 full threshold algorithm with the updated version of Elisar 30-2 full threshold algorithm and with 30-2 full threshold algorithm of Humphrey visual field analyzer.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/04/024647
Enrollment
109
Registered
2020-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H409- Unspecified glaucoma

Interventions

Control Intervention1: NA: NA

Sponsors

Dr Amar Agarwal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Abnormal subjects consist of both Glaucoma and other conditions with decibel values of less than 9 dB in HFA will be included in the study For controls: 2.The best-corrected visual acuity of 6/12 or better as measured with Snellenâ??s visual acuity char

Exclusion criteria

Exclusion criteria: 1. Patients who had undergone ocular surgeries (other than cataract surgery), patients with ocular disease, amblyopia, neurological disorders will be excluded from the study. 2. Patients using a miotic drug will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
To establish the equivalence between threshold estimates of updated algorithm of 30-2 Elisar AVA and the 30-2 of Humphrey visual field analyserTimepoint: 45 days—

Secondary

MeasureTime frame
To establish the equivalence between threshold estimates of updated algorithm of 30-2 Elisar AVA and the 30-2 of Humphrey visual field analyserTimepoint: 45 days—

Countries

India

Contacts

Public ContactMaheswari Srinivasan

Dr. Agarwals eye hospitals

maheswari.srinivasan@dragarwal.com09841661134

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026